Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sun Dec 18 08:03:23 UTC 2022
by
admin
on
Sun Dec 18 08:03:23 UTC 2022
|
Protein Type | RECEPTOR |
Protein Sub Type | |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
UKK18ES9TF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
P08908
Created by
admin on Sun Dec 18 08:03:27 UTC 2022 , Edited by admin on Sun Dec 18 08:03:27 UTC 2022
|
PRIMARY | |||
|
P08908
Created by
admin on Sun Dec 18 08:03:27 UTC 2022 , Edited by admin on Sun Dec 18 08:03:27 UTC 2022
|
PRIMARY | |||
|
UKK18ES9TF
Created by
admin on Sun Dec 18 08:03:27 UTC 2022 , Edited by admin on Sun Dec 18 08:03:27 UTC 2022
|
PRIMARY |
From | To |
---|---|
1_109 | 1_187 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_10 |
N | 1_11 |
N | 1_24 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
PARTIAL AGONIST->TARGET |
Ki
|
||
|
WEAK INHIBITOR->TARGET |
INHIBITOR
Ki
|
||
|
RADIOLIGAND->TARGET |
Kd
|
||
|
PARTIAL AGONIST->TARGET |
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET |
|
||
|
PARTIAL AGONIST->TARGET | |||
|
AGONIST -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET |
AGONIST
Ki
|
||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET |
|
||
|
RADIOLIGAND->TARGET | |||
|
ACTIVATOR -> TARGET | |||
|
INHIBITOR -> TARGET |
Exhibited antagonism activity at both presynaptic and postsynaptic 5-HT1A receptor sites.
Kd
|
||
|
PARTIAL AGONIST->TARGET |
Kd
|
||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET | |||
|
LIGAND->TARGET |
|
||
|
PARTIAL AGONIST->TARGET | |||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET |
The strongest receptor binding affinity for 5-MeO-DiPT is at the 5-HT1A receptor.
|
||
|
AGONIST -> TARGET |
SELECTIVE
|
||
|
PARTIAL AGONIST->TARGET | |||
|
PARTIAL AGONIST->TARGET |
Ki
|
||
|
AGONIST -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
AGONIST -> TARGET |
Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors
BINDING
|
||
|
PARTIAL AGONIST->TARGET | |||
|
RADIOLIGAND->TARGET |
|
||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET | |||
|
RADIOLIGAND->TARGET |
Kd
|
||
|
RADIOLIGAND->TARGET |
|
||
|
PARTIAL AGONIST->TARGET | |||
|
INHIBITOR -> TARGET |
INHIBITOR
Ki
|
||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET |
|
||
|
RADIOLIGAND->TARGET |
Kd
|
||
|
RADIOLIGAND->TARGET |
Kd
|
||
|
RADIOLIGAND->TARGET |
|
||
|
AGONIST -> TARGET |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT | CHEMICAL |
|